Mangoceuticals reprices CEO's 2.1M stock options down 80% to $0.45 amid stock decline
Filed March 17, 2026 · Period ending March 16, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade MGRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 4, 2026 9:48 PM